Immunomodulatory drug maintenance therapy vs placebo/observation
Grades 3 and 4 adverse events · people with chronic lymphocytic leukaemia
Immunomodulatory drug maintenance therapy may leads to higher grade 3/4 adverse events compared with placebo/observation (low certainty).
1 finding from 1 review
- Rate ratio 1.82 [1.38, 2.38]2 studies · 400 participantsLow